Skip to content

Armodafinil

Also called Nuvigil — sold as Waklert and Artvigil; the R-enantiomer of modafinil

The R-enantiomer of modafinil, which is a 1:1 racemate. The eugeroic action is taken to be dopamine transporter blockade, but that was measured on the racemate and no imaging study of this enantiomer alone has ever been published.

  • TypeSmall molecule
  • FormOral
  • Researched forCognitive & Mood

Where to get Armodafinil

RUPharma
Oral
Code CAMERON

Sold as the form named. Approved uses are on its label; the research here goes beyond them.

Shop oral at RUPharma
Before you run this, know your numbers

The R-enantiomer of modafinil, and the same schedule and the same three approved indications.

Same CYP3A4 induction as modafinil, and the same reason to know your hormone numbers if you are running anything. The longer effective half-life is why the afternoon dose is the one that costs you sleep.

Order these through my Marek link

The short version

  • Why people research itFocus, memory, neuroprotection, mood and stress resilience.
  • What the evidence isThe pivotal trials moved Maintenance of Wakefulness Test sleep latency by +1.3 to +2.6 minutes against placebo changes of -1.3 to -1.9 minutes — a drug-placebo gap of 3.2 to 4.5 minutes, printed in the label's own efficacy table.
  • What to watchSkin rash with fever or mouth sores.

How Armodafinil works

This is not a new molecule. It is half of an old one, sold whole.

What was removed, and why anybody bothered. The two halves do not clear at the same rate. Provigil label 2025 states that R-modafinil's half-life is approximately three times that of S-modafinil in adult humans.

R-modafinil's half-life is about three times S-modafinil's, so an enantiopure tablet delivers the slow-clearing half alone. Amide hydrolysis is the dominant metabolic route with sulfone formation by CYP3A4/5 next; under 10% leaves as parent drug in urine. Induces CYP3A4, inhibits CYP2C19.

  • Oral

On the goal map: Catecholamine & dopaminergic drive (Focus, memory & cognition)

Research on Armodafinil6 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: FDA-approved for obstructive sleep apnea, narcolepsy and shift work disorder — Schedule IV controlled substance.

Human clinical evidence

  • FDA-approved, Schedule IV, for the same three indications as modafinil. The pivotal trials moved Maintenance of Wakefulness Test sleep latency by +1.3 to +2.6 minutes against placebo changes of -1.3 to -1.9 minutes — a drug-placebo gap of 3.2 to 4.5 minutes, printed in the label's own efficacy table.

  • The evidence base cannot separate it from modafinil. The 14-trial, 3085-patient network meta-analysis entered the two as a single treatment node (Pitre 2023). Later syntheses compared them only indirectly (Ronnebaum 2021; Tanayapong 2025) — because no head-to-head randomized trial exists.

Correlative data

  • That is the clearest statement anywhere that this is not a second drug.

  • Community use mirrors modafinil's, with the reported difference being a smoother, later-running day. Consistent with R-modafinil's roughly three-fold longer half-life, and never tested against it.

How the mechanism reads

  • No positron-emission study has ever imaged this enantiomer. Every transporter number attributed to it belongs to the racemate, and the inference assumes the S-enantiomer contributed nothing — which nobody has checked.

    Mechanistic
  • The largest practical difference from modafinil is a food effect: peak concentration is delayed 2 to 4 hours when taken fed, against about one hour for modafinil.

    Mechanistic

Sources

  • U.S. Food and Drug Administration. NUVIGIL (armodafinil) tablets, C-IV - full prescribing information, including the Maintenance of Wakefulness Test results from the three pivotal trials and the physical dependence and withdrawal statements. DailyMed, U.S. National Library of Medicine; Cephalon LLC label version 32, revised May 2025
  • U.S. Food and Drug Administration. PROVIGIL (modafinil) tablets, C-IV - full prescribing information, including the serious rash warning, the mechanism-of-action statement, the CYP3A4/5 induction and CYP2C19 inhibition sections and the drug abuse and dependence section. DailyMed, U.S. National Library of Medicine; Cephalon LLC label version 23, revised March 2025
  • Pitre T. Comparative Efficacy and Safety of Wakefulness-Promoting Agents for Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea: A Systematic Review and Network Meta-analysis. Annals of Internal Medicine 2023 · PMID 37155992
  • Ronnebaum S. Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea. Journal of Clinical Sleep Medicine 2021 · PMID 34402784
  • Tanayapong P. Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Residual Sleepiness in Obstructive Sleep Apnea Despite Continuous Positive Airway Pressure: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials. CNS Drugs 2025 · PMID 40208562
  • Hersey M, Tanda G. Modafinil, an atypical CNS stimulant?. Advances in Pharmacology 2024;99:287-326 · PMID 38467484
  • Volkow ND, Fowler JS, Logan J, Alexoff D, Zhu W, Telang F, Wang GJ, Jayne M, Hooker JM, Wong C, et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 2009;301(11):1148-1154 · PMID 19293415

Armodafinil safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • Arrhythmia, left ventricular hypertrophy or uncontrolled hypertension.
  • A rash on modafinil in the past, because serious skin reactions are labeled.
  • Psychosis, bipolar mania or an anxiety disorder that stimulants worsen.
  • Pregnancy, where modafinil-class drugs are linked to birth defects in registry data.
  • Using hormonal contraception, since CYP3A4 induction can blunt its effect.

What’s expected

  • Wakefulness and sustained attention from dopamine transporter blockade.
  • Headache, nausea and reduced appetite.
  • Delayed sleep onset because the R-enantiomer lasts longer than the racemate.

Watch for

  • Skin rash with fever or mouth sores.
  • Chest pain or palpitations from dopaminergic stimulation of the heart.
  • Heavy fatigue, low mood and sleep crash when stopping.

Labs that tell you it’s working

  • Comprehensive Metabolic Panel: liver enzymes, since modafinil-class drugs are hepatically cleared.
  • Complete Blood Count: eosinophils and white cells if a drug rash appears.

R-enantiomer of modafinil; wake-promotion via dopamine transporter inhibition, labeled for physical dependence on abrupt cessation. PMID 19293415 PMID 38467484

Also on the record

  • Prescription-only and a Schedule IV controlled substance in the US. Its label states physical dependence can occur and lists withdrawal symptoms on abrupt cessation. Same serious-rash warning and same CYP3A4 contraceptive interaction as modafinil.

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

Armodafinil FAQ4 common questions

Is Armodafinil approved for human use?
Armodafinil is an approved medicine for the uses on its label. This page covers research beyond those uses, as education, not medical advice.
What is Armodafinil researched for?
Focus, memory, neuroprotection, mood and stress resilience.
Which labs show whether it's doing anything?
Comprehensive Metabolic Panel; Complete Blood Count: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Armodafinil: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Armodafinil is. Skool covers how it is run.

Free on this page

What Armodafinil is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Armodafinil is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool